Therapeuticsmd Inc (TXMD) - News Archive

TherapeuticsMD, Inc., a company that notably owns the rights to pharmaceutical royalties (NASDAQ: TXMD), has recently announced their first quarter financial results for the fiscal year 2024. As a respected journal in t...

TherapeuticsMD Reports First Quarter 2024 Financial Results with Net Loss from Continuing OperationsTherapeuticsMD, Inc. (TherapeuticsMD or the Company) (NASDAQ: TXMD) recently released its financial results for the fir...

TherapeuticsMD Inc. Reports Steady Financial Growth in the First Quarter of 2024In an impressive display of financial stability, TherapeuticsMD Inc. (NASDAQ: TXMD) has announced its first quarter 2024 financial results,...

As the first quarter of 2024 concludes, TherapeuticsMD, Inc. (NASDAQ: TXMD), a healthcare-focused company specialising in securing royalties for pharmaceutical products, has made considerable strides towards achieving i...